Market Closed -
OTC Markets
03:41:35 2024-04-23 pm EDT
|
5-day change
|
1st Jan Change
|
35.35
USD
|
+1.18%
|
|
+0.53%
|
+1.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
358.3
|
324.9
|
368
|
411.5
|
255.6
|
338.9
|
Enterprise Value (EV)
1 |
326.6
|
310.6
|
360.8
|
406.1
|
247.9
|
329.2
|
P/E ratio
|
22.9
x
|
13.3
x
|
24.3
x
|
38.4
x
|
-15.8
x
|
6.17
x
|
Yield
|
2.92%
|
3.22%
|
2.84%
|
2.54%
|
2.61%
|
1.6%
|
Capitalization / Revenue
|
0.78
x
|
0.63
x
|
0.7
x
|
0.81
x
|
0.54
x
|
0.61
x
|
EV / Revenue
|
0.71
x
|
0.61
x
|
0.69
x
|
0.8
x
|
0.52
x
|
0.59
x
|
EV / EBITDA
|
14.2
x
|
8.21
x
|
14.8
x
|
26.4
x
|
-17.5
x
|
4.42
x
|
EV / FCF
|
-2.05
x
|
7.93
x
|
18.9
x
|
4.93
x
|
-0.57
x
|
3.07
x
|
FCF Yield
|
-48.8%
|
12.6%
|
5.29%
|
20.3%
|
-175%
|
32.6%
|
Price to Book
|
0.52
x
|
0.4
x
|
0.4
x
|
0.5
x
|
0.52
x
|
0.56
x
|
Nbr of stocks (in thousands)
|
9,683
|
9,683
|
9,683
|
9,683
|
9,683
|
9,683
|
Reference price
2 |
37.00
|
33.55
|
38.00
|
42.50
|
26.40
|
35.00
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/5/21
|
3/4/22
|
3/7/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
461
|
512.7
|
523.9
|
505.8
|
476.6
|
558.9
|
EBITDA
1 |
22.99
|
37.82
|
24.45
|
15.39
|
-14.16
|
74.56
|
EBIT
1 |
17.19
|
29.45
|
15.91
|
7.42
|
-20.76
|
69.31
|
Operating Margin
|
3.73%
|
5.74%
|
3.04%
|
1.47%
|
-4.35%
|
12.4%
|
Earnings before Tax (EBT)
1 |
17.19
|
29.45
|
15.91
|
12.92
|
-20.76
|
69.31
|
Net income
1 |
15.67
|
24.43
|
15.17
|
10.7
|
-16.22
|
54.92
|
Net margin
|
3.4%
|
4.76%
|
2.9%
|
2.12%
|
-3.4%
|
9.83%
|
EPS
2 |
1.618
|
2.523
|
1.567
|
1.105
|
-1.675
|
5.672
|
Free Cash Flow
1 |
-159.5
|
39.17
|
19.1
|
82.35
|
-434.4
|
107.3
|
FCF margin
|
-34.59%
|
7.64%
|
3.65%
|
16.28%
|
-91.14%
|
19.2%
|
FCF Conversion (EBITDA)
|
-
|
103.57%
|
78.11%
|
535.22%
|
-
|
143.92%
|
FCF Conversion (Net income)
|
-
|
160.35%
|
125.91%
|
769.38%
|
-
|
195.39%
|
Dividend per Share
2 |
1.080
|
1.080
|
1.080
|
1.080
|
0.6900
|
0.5600
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/5/21
|
3/4/22
|
3/7/23
|
3/6/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
31.7
|
14.2
|
7.2
|
5.42
|
7.77
|
9.7
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-159
|
39.2
|
19.1
|
82.4
|
-434
|
107
|
ROE (net income / shareholders' equity)
|
2.19%
|
3.25%
|
1.76%
|
1.23%
|
-2.45%
|
9.98%
|
ROA (Net income/ Total Assets)
|
0.23%
|
0.36%
|
0.19%
|
0.09%
|
-0.25%
|
0.86%
|
Assets
1 |
6,935
|
6,763
|
8,147
|
12,578
|
6,500
|
6,351
|
Book Value Per Share
2 |
71.40
|
83.70
|
93.80
|
85.80
|
50.80
|
62.90
|
Cash Flow per Share
2 |
3.270
|
1.470
|
0.7400
|
0.5600
|
0.8000
|
1.000
|
Capex
1 |
19.5
|
2.38
|
1.84
|
0.63
|
0.54
|
0.92
|
Capex / Sales
|
4.23%
|
0.46%
|
0.35%
|
0.12%
|
0.11%
|
0.16%
|
Announcement Date
|
3/7/19
|
3/12/20
|
3/5/21
|
3/4/22
|
3/7/23
|
3/6/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.00% | 342M | | +3.05% | 95.15B | | +1.78% | 94.71B | | -20.65% | 77.24B | | +18.68% | 74.93B | | +6.69% | 30.04B | | +18.06% | 27.87B | | +4.32% | 26.97B | | -1.21% | 16.99B | | -9.10% | 15.16B |
Life Insurance
|